Replies to post #304629 on NorthWest Biotherapeutics Inc (NWBO)

[tryn2]

Northwest Biotherapeutics CEO, Linda Powers will present DCVax® Personalized Immune Therapies on 9/12/20 at the American Brain Tumor Association (ABTA) virtual 2020 National Conference (see pg. 6): DCVax® Personalized Immune Therapies: Explanation of what dendritic cell therapies (such as DCVax) are, how they work and how they are different from other kinds of treatments for Glioblastoma (see page 6):

https://www.abta.org/wp-content/uploads/2020/09/2020-National-Conference-VIRTUAL-Program-Final_9.1.2020.pdf

[erik007tc]

Me too... just feels right, timing wise.